Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Rossi

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
JCI Insight|October 13, 2020
Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumorsDaniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, et al.
Biomedicines|February 27, 2026
<i>PIK3CA</i> Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted PatientsSabrina Rossi, Arianna Pagliaro, Silvia Masini, et al.
Molecular Diagnosis & Therapy|November 28, 2015
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional StudyVincenzo Dadduzio, Michele Basso, Sabrina Rossi, et al.
Mutagenesis|November 8, 2012
DNA damage response in monozygotic twins discordant for smoking habitsFrancesca Marcon, Daniela Carotti, Cristina Andreoli, et al.
Molecular and Cellular Biology|September 18, 2013
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformationEros Di Giorgio, Andrea Clocchiatti, Sara Piccinin, et al.
Plos Genetics|April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressivenessEros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytomaSabrina Rossi, Kàroly Szuhai, Marije Ijszenga, et al.
NPJ Precision Oncology|August 20, 2025
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous systemAlba Clara Fernández-Rilo, Emmanuel de Billy, Giada Del Baldo, et al.
Pathology, Research and Practice|July 30, 2021
DICER1-associated malignancies mimicking germ cell neoplasms: Report of two cases and review of the literatureSabrina Rossi, Sabina Barresi, Alessandra Stracuzzi, et al.
Oncotarget|May 10, 2014
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypesErica Lorenzetto, Monica Brenca, Mattia Boeri, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
JCI Insight|October 13, 2020
Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumorsDaniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, et al.
Biomedicines|February 27, 2026
<i>PIK3CA</i> Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted PatientsSabrina Rossi, Arianna Pagliaro, Silvia Masini, et al.
Molecular Diagnosis & Therapy|November 28, 2015
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional StudyVincenzo Dadduzio, Michele Basso, Sabrina Rossi, et al.
Mutagenesis|November 8, 2012
DNA damage response in monozygotic twins discordant for smoking habitsFrancesca Marcon, Daniela Carotti, Cristina Andreoli, et al.
Molecular and Cellular Biology|September 18, 2013
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformationEros Di Giorgio, Andrea Clocchiatti, Sara Piccinin, et al.
Plos Genetics|April 19, 2017
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressivenessEros Di Giorgio, Elisa Franforte, Sebastiano Cefalù, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytomaSabrina Rossi, Kàroly Szuhai, Marije Ijszenga, et al.
NPJ Precision Oncology|August 20, 2025
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous systemAlba Clara Fernández-Rilo, Emmanuel de Billy, Giada Del Baldo, et al.
Pathology, Research and Practice|July 30, 2021
DICER1-associated malignancies mimicking germ cell neoplasms: Report of two cases and review of the literatureSabrina Rossi, Sabina Barresi, Alessandra Stracuzzi, et al.
Oncotarget|May 10, 2014
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypesErica Lorenzetto, Monica Brenca, Mattia Boeri, et al.
Pageof 19